Smoking Associated with Worse Outcomes in Patients with Prostate Cancer Treated by Radical Radiother

	Tweet

Smoking Associated with Worse Outcomes in Patients with Prostate Cancer Treated by Radical Radiotherapy
A history of smoking is associated with an increased risk of metastatic disease in patients treated with radiotherapy (XRT) for prostate cancer (CaP), according to a report in the online version of the BJU International. The work is published by Dr. Pantarotto and colleagues in Ottawa, Canada.

In this retrospective review, 434 patients were treated with 66Gy of definitive radiotherapy between 1990 and 1999. To be included, patients had a PSA level less than 100ng/ml and no clinical or radiographic evidence of lymph node or distant metastasis.

A smoking history categorized patients as non-smokers, previous smokers (>6 months smoking history but not smokers at time of consultation) or current smokers. Biochemical failure was defined by ASTRO criteria. Data regarding time to biochemical failure, time to local failure, time to distant failure, overall survival and disease-specific survival were generated.

A smoking history was obtained in 416 of 434 patients (96%) and the lifetime prevalence of smoking was 71%. Current smokers constituted 17% and non-smokers 29% of the cohort. Median follow-up was 70 months and current smokers presented at a younger median age of 66.4 years, compared with 69.9 years for previous smokers and 70 years for non-smokers. Clinical T stage, Gleason score and initial PSA were not significantly different between the smoking categories.

Biochemical, local and distant failure occurred in 44.6%, 23.2%, and 15.5% of patients, respectively. While biochemical and local failure rates were similar among smoking groups, a higher proportion of current smokers had distant failure events. Disease-specific survival was not significantly different among the three smoking groups, whereas overall survival was worse for current smokers than non-smokers (46% vs. 26%). The cohort death rate was 34%, with 39% of those deaths due to CaP. In univariate analysis, both previous and current smoking was associated with higher distant failure rates. In multivariate analysis, previous and current smokers had a higher risk of distant failure, 2.90 and 5.24, respectively. Overall and CaP-specific survival were not significantly different among the three smoking groups.

Several mechanisms have been proposed regarding the impact of smoking on CaP patient outcomes to XRT. Smoking-induced hypoxia secondary to high serum carboxyhemoglobin levels that interfere with hemoglobin-oxygen dissociation is thought to significantly contribute. Smoking also likely affects cellular mechanisms that result in tumor progression.

Jason Pantarotto, Shawn Malone, Simone Dahrouge, Victor Gallant and Libni Eapen

BJU Int 2006; 99(3): 564-569

By Christopher P. Evans, MD

Source: UroToday

RELATED STORIES:
Folate may alter risk of prostate cancer progression   Prostate Cancer - Patterns of Progression   Prostate cancer increases hip fracture risk by eight times in 50 to 65 year-olds   Louis Gossett Jr. fighting prostate cancer   Should older men be screened for prostate cancer?   Gene test could save men from prostate surgery   Lean body mass may protect against prostate cancer   New research model of human prostate cancer shows cancer development   Combination therapy improves survival for certain prostate cancer patients   Prostate cancer therapy not tied to bladder cancer   New test can predict return of prostate cancer   Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy   Testosterone Replacement in Older Men Does Not Increase Risk of Prostate Cancer   Vaccine Approach Extends Life of Metastatic Prostate Cancer Patients   Patients who refuse prostate cancer surgery have worse long-term survival   Fit Friday: Reducing prostate cancer death risk, diet’s role in asthma, workout clothes   Omega-3s cut risk of advanced prostate cancer   Pomegranate Juice Slows PSA Acceleration Rate After Prostate Cancer Surgery, Radiation   Genetic and Behavioral Differences Add to Prostate Cancer Disparities   Low PSA may not rule out prostate cancer   Artificial Light at Night: Higher Risk of Prostate Cancer   Childless men run lower risk of prostate cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]